ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print July 2, 2009, 10.1183/09031936.00009709
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/6/1390    most recent
09031936.00009709v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Kizawa, T.
Right arrow Articles by Inoue, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kizawa, T.
Right arrow Articles by Inoue, H.
Eur Respir J 2009; 34:1390-1398
Copyright ©ERS Journals Ltd 2009

Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea

T. Kizawa1, Y. Nakamura1, S. Takahashi2, S. Sakurai3, K. Yamauchi1 and H. Inoue1

1 Division of Pulmonary Medicine, Allergy, and Rheumatology, Dept of Internal Medicine, 2 Dept of Critical Care Medicine, and 3 Dept of Laboratory Medicine, Iwate Medical University School of Medicine, Morioka, Japan.

CORRESPONDENCE: Y. Nakamura, Division of Pulmonary Medicine, Allergy, and Rheumatology, Dept of Internal Medicine, Iwate Medical University School of Medicine, 19-1 Uchimaru, Morioka, 020-8505 Japan. E-mail: ICB75097{at}nifty.com

Keywords: Angiogenesis, continuous positive airway pressure, obstructive sleep apnoea, oxidant stress, vascular endothelium

Received: January 20, 2009
Accepted May 7, 2009

A sustained elevation of oxidative stress in patients with obstructive sleep apnoea syndrome (OSAS) might help to explain their increased risk for cardiovascular diseases. We tested the hypothesis that the values of oxidative stress are increased in otherwise healthy subjects with OSAS when compared with closely matched control subjects.

We performed a prospective study of 38 subjects who did not have OSAS and 37 patients with OSAS. Plasma indices of angiotensin (Ang) II, vascular endothelial growth factor (VEGF), oxidised low-density lipoprotein (oxLDL), and circulating endothelial precursor cells (CEPs) were measured in OSAS patients and in matched controls. Peripheral blood mononuclear cells (PBMCs) were obtained from both groups and co-cultured with endothelial cells to examine the effects on tube formation.

The OSAS group showed increased levels of Ang II, VEGF, oxLDL and CEPs, which were decreased after nasal continuous positive airway pressure (nCPAP) treatment. In vitro, PBMCs from the OSAS group induced tube formation. Ang II, oxLDL, and Ang II-stimulated PBMCs induced lectin-like oxLDL receptor (LOX-1) expression and VEGF receptor-2 activation on endothelial cells, respectively.

These observations suggest an important role of Ang II and oxLDL-mediated LOX-1 upregulation in endothelial cell injury in patients with OSAS.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.